In recent years, there is an emergence of antibiotic-resistant bacterial strains due to the indiscriminate use of antibiotics, commonly prescribed to treat infectious diseases. The increasing occurrence of antibiotic resistance has undoubtedly made bacterial infections a greater health risk and threat than before. In this project, the use of natural polyphenolic compounds, extracted from green tea (Camellia sinensis) and banana (Musa sp.) leaves, as a novel antimicrobial chemotherapeutic agent was investigated. This study examined their bactericidal effects on Escherichia coli and Micrococcus luteus, and also evaluated the potential synergistic ability of these polyphenol-rich extracts when used alongside the beta-lactam antibiotic ampicillin. For the same dry mass of plant material used (3g), the prepared green tea extract had a higher total polyphenol concentration than that of banana leaves extract (495.1mg/L as compared to 221.6mg/L respectively). Subsequently, bacterial broth of 10 5 colony forming units/ml was mixed with varying concentrations of the different test compounds before plating 10µl of the mixture and quantifying the compounds' bactericidal effect by doing a viable count after overnight incubation. The green tea extract showed the greatest bactericidal effect on E. coli and M. luteus as compared to the banana leaves extract and ampicillin. Against E. coli, this difference was confirmed to be significant (p<0.05) using one-way ANOVA and Tukey's post-hoc analysis. 
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INTRODUCTION 19
According to a study done by CDC (Center for Disease Control and Prevention), in the United 20
States alone, food-borne diseases account for 76 million diseases, 325,000 hospitalizations and 21 5,000 deaths each year; and bacterial infections make up for approximately 5 million of these 22 diseases, which is around 13% of the 38.6 million food-related diseases caused by known 23 pathogenic bacteria [1] . 24
25
Modern medicine relies heavily on the use of antibiotics to kill pathogenic bacteria. However, 26 in the recent years, the emergence of antibiotic resistant bacteria has become a global concern 27 as seen in the recent emergence of multiple drug-resistant 'superbugs' found in hospitals in 28 countries like India, London and Nottingham. These 'superbugs' are resistant to even the most 29 powerful of modern antibiotics [2] . Scientific research has shown that tetracycline and 30 erythromycin resistance among bacteria are encoded by over 100 different genetic 31 mechanisms, several of which are readily transferable to other bacteria via conjugation [3] . 32
Hence, many bacterial strains have gained resistance to the popular beta-lactam antibiotics, 33 which include ampicillin and oxacillin [4] . 34
35
Polyphenolic antioxidants such as catechins occur most abundantly in green tea (leaves of 36
Camellia sinensis that have undergone minimal oxidation during processing). Banana (Musa 37 sp.) leaves, though commonly thrown away, also contain large amounts of polyphenols, 38 including epigallocatechin gallate (EGCG), similar to green tea [5] . EGCG is 100 times more 39 potent than vitamin C and 25 times more potent than vitamin E in terms of antioxidant power 40
[6]. The extraction of polyphenolic compounds from banana leaves and green tea leaves for 41 use as an antimicrobial agent would surely be a natural and low-cost treatment method. 42
Furthermore, due to the complicated biochemical structure of these polyphenolic compounds, 43 it is therefore difficult for bacteria to develop resistance against it [7] . This study therefore 44
investigates the antimicrobial properties of banana leaves and green tea extracts. The two main 45 objectives are: (1) to assay the antimicrobial effect of the polyphenol-rich extracts on 46
Micrococcus luteus (gram-positive bacteria) and Escherichia coli (gram-negative bacteria), 47 and (2) to evaluate the ability of these polyphenol compounds to work synergistically with β-48 lactam antibiotic ampicillin (a widely-prescribed moderate-spectrum antibiotic) to render M. Where Mi -Mj is the difference between the i th and j th means, MSE is the Mean Square Error (an estimate of the population variance in the analysis of variance), and n is the mean of the sample sizes of groups i and j.
The produced p-value can then be used to determine
As ANOVA test does not specify which means differ significantly. Thus, it was necessary to conduct post-hoc Tukey's HSD which allows for multiple pair-wise comparisons.
Tukey's HSD test basically avoids the need to perform multiple independent-sample ttests to test all possible pairs of treatments as it can determine which of three or more sample means are significantly different. The problem with doing multiple t-tests is that the type I error ("false positive" results) rate will increase with the number of comparisons made.
whether the means tested are significantly different:
-When p>0.05 (or 5%), then the difference is not significant (and might be due to chance).
-When p<0.05 (or 5%), then the difference is significant.
-When p<0.01 (or 1%), then the difference is very significant.
-When p<0.001 (or 0.1%), then the difference is extremely significant. 
101
Compound
From the antimicrobial assay done, we can infer that apart from ethyl acetate (the solvent used 159 to extract the polyphenolic compounds from green tea and banana leaves), the other compounds 160 tested all showed antimicrobial activity (to varying degrees) towards E. coli and M. luteus. 161
162
The total number of visible bacteria colonies of each of the dilution factors for each trial was 163 counted using a colony counter which electronically keeps track of the number of colony 164 counted, and a black marker was also used to mark every colony counted. In order to better 165 gauge the antimicrobial efficacy of these test extracts and combinations, Tukey's Honestly 166
Significant Difference (HSD) analysis was done to conduct an all pairs comparison for the 167 average number of bacterial colonies counted for the lowest concentration of the various 168 compounds and combinations (1/128 or 2 -7 ) tested. The produced p-value (shown in Graphs 1 169 and 2) can then be used to determine which test extract or combination is a significantly more 170 effective treatment method (at the lowest concentration tested) against E. coli and M. luteus. 171
The rationale behind this is to determine the antimicrobial compound which is the most 172
effective at the lowest concentration tested; so as to enable a lower concentration/ dosage 173 antibiotic [14] , and (iii) inhibition of efflux pumps thus allowing accumulation of the antibiotic 221 within the bacterial cell [15] . 
